ASXL-Related Disorders Natural History Study

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 20, 2017

Primary Completion Date

September 30, 2037

Study Completion Date

September 30, 2037

Conditions
Bohring-Opitz SyndromeASXL1 Gene MutationShashi-Pena SyndromeASXL2 Gene MutationBainbridge-Ropers SyndromeASXL3 Gene Mutation
Trial Locations (1)

90095

RECRUITING

University of California, Los Angeles, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boston Children's Hospital

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

Duke University

OTHER

lead

University of California, Los Angeles

OTHER